Home › NDC Lookup › RxCUI directory › RxCUI 1945039

14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0... — RxCUI 1945039

RxNorm drug concept · Semantic clinical drug
RxCUI 1945039 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1945039
Official name14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT; fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters
FDA products mapped2
Package NDCs mapped6
Reported Medicaid activity (SDUD)766,474 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluticasone Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — fluticasone is a preventive inhaler, not a rescue inhaler. It works by slowly reducing airway inflammation over days to weeks, so it won't open your airways fast enough during...
  • Can I use my fluticasone inhaler when I'm having an asthma attack?
  • Great question — this is one of the most practical things you can do. When you inhale fluticasone, some of the medication can land in your mouth and throat rather than making it al...
  • Why do I need to rinse my mouth after using it?
📖 Read our full Fluticasone Oral Inhalation guide →

🕸️ Concept Web — How 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / um... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler RxCUI 1945039

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Fluticasone 41126
    • Umeclidinium 1487514
    • Vilanterol 1424884
    • Fluticasone / umeclidinium / vilanterol 1945038
    • Fluticasone furoate 705022
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trelegy 1945040
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluticasone / umeclidinium / vilanterol Dry Powder Inhaler 1945037
    • Fluticasone furoate / umeclidinium / vilanterol Dry Powder Inhaler 2648696
    • Fluticasone / umeclidinium / vilanterol Inhalant Product 1945036
    • Fluticasone furoate / umeclidinium / vilanterol Inhalant Product 2663247
    • Fluticasone / umeclidinium / vilanterol Dry Powder Inhaler [Trelegy] 1945042
    • Fluticasone furoate / umeclidinium / vilanterol Dry Powder Inhaler [Trelegy] 2656072
    • Trelegy Inhalant Product 1945043
    • Dry Powder Inhaler 744995
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 19 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluticasone furoate 0.1 MG/ACTUAT SCDC · 1424882
  • Umeclidinium 0.0625 MG/ACTUAT SCDC · 1487515
  • Vilanterol 0.025 MG/ACTUAT SCDC · 1424885
  • Fluticasone / umeclidinium / vilanterol Dry Powder Inhaler SCDF · 1945037
  • Fluticasone furoate / umeclidinium / vilanterol Dry Powder Inhaler SCDFP · 2648696
  • Fluticasone / umeclidinium / vilanterol Inhalant Product SCDG · 1945036
  • Fluticasone furoate / umeclidinium / vilanterol Inhalant Product SCDGP · 2663247

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 1945039 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00173-0887-10 1 TRAY in 1 CARTON (0173-0887-10) / 1 INHALER in 1 TRAY / 3... Trelegy Ellipta GlaxoSmithKline LLC 2017-09-18
00173-0887-14 1 TRAY in 1 CARTON (0173-0887-14) / 1 INHALER in 1 TRAY / 1... Trelegy Ellipta GlaxoSmithKline LLC 2017-09-18
00173-0887-61 1 TRAY in 1 CARTON (0173-0887-61) / 1 INHALER in 1 TRAY / 1... Trelegy Ellipta GlaxoSmithKline LLC 2017-09-18
00173-0893-10 1 TRAY in 1 CARTON (0173-0893-10) / 1 INHALER in 1 TRAY / 3... Trelegy Ellipta GlaxoSmithKline LLC 2020-09-09
00173-0893-14 1 TRAY in 1 CARTON (0173-0893-14) / 1 INHALER in 1 TRAY / 1... Trelegy Ellipta GlaxoSmithKline LLC 2020-09-09
00173-0893-61 1 TRAY in 1 CARTON (0173-0893-61) / 1 INHALER in 1 TRAY / 1... Trelegy Ellipta GlaxoSmithKline LLC 2020-09-09
Observed labelers: GlaxoSmithKline LLC (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.